H

Human Longevity, Inc.

80 employees

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

Investor insights

Sectors invested in

Biotechnology4

Health Care4

Therapeutics2

Medical2

Wellness2

Nutrition1

Personal Health1

Medical Device1

Life Science1

Medical Devices1

Medical Device Therapeutics1

Vitamin D1

Health1

Phototherapy1

gut health1

food and nutrition1

probiotics1

microbiome1

Funding rounds participated in

$24M sweet spot round size

Most of their 4 investments are in rounds between $9.3M and $24M

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Executive Physicals

DNA Sequencing

Whole Genome Sequencing

Cancer Risk Assessments

Health Diagnostics

RNA Sequencing

Health Care

Health Risk Assessments

Genetics

Cancer Exome Sequencing

Metabolome Analysis

Microbiome Sequencing

Magnetic Resonance Imaging (MRI)

Date founded

2013

Investments made

S

Sun Genomics raised $9.3M on June 29, 2020

Investors: SOSV - The Accelerator VC, Danone Manifesto Ventures, Pangaea Ventures and Human Longevity, Inc.

S

SOLIUS raised undisclosed on May 13, 2020

Investors: Human Longevity, Inc.

C

Celularity, Inc. raised $250M on February 15, 2018

Investors: Section 32, Sorrento Therapeutics, Inc., United Therapeutics Corporation, Heritage Group, Celgene and Human Longevity, Inc.

O

OxStem Limited raised $24M on May 10, 2016

Investors: Human Longevity, Inc.

Funding rounds raised

Total raised

$220M

from 9 investors over 9 rounds

H

Human Longevity, Inc. raised $220M on April 5, 2016

Investors: GE Ventures, Celgene, OS Fund, Threshold Ventures and Illumina Ventures

H

Human Longevity, Inc. raised $80M on March 4, 2014

Investors: Celgene, Synthetic Genomics and OS Fund

H

Human Longevity, Inc. raised undisclosed on January 1, 2014

Investors: Singularity University Ventures